Kat Korhonen

Scientist I / Lab Manager at Cytokinetics

Kat Korhonen currently serves as a Scientist I and Lab Manager at Cytokinetics, focusing on developing animal models for testing drug therapies aimed at muscular degenerative diseases. This role includes model validation and post-data processing, along with extensive experience in pharmacodynamic studies involving various techniques such as echocardiography and transcriptome analysis. Prior experience at the University of Connecticut included positions as a Graduate Research Student, where research centered on Streptococcus pneumonia infection in Sickle Cell Disease and the role of host protein Cyclophilin A in poxvirus replication, contributing to potential antiviral drug target insights. Kat Korhonen holds a Master’s Degree in Pathobiology and a Bachelor’s Degree in Molecular and Cell Biology with a minor in Physiology from the University of Connecticut.

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Cytokinetics

16 followers

Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.


Industries

Employees

201-500

Links